| Rus |  |
Eng |  |
Carbon 2012 is an international conference dedicated to the latest advancements in the science, technology and applications of carbon. The conference will provide a forum for academic and industrial researchers, engineers, students and innovators to summarize the recent achievements and research activities made in the area of carbon. The aim of the conference will be also to facilitate and promote the need of international collaboration and knowledge exchange in carbon materials, while preserving the dynamic competitiveness in research and its commercial applications.
June 17 - 22, 2012 Krakow, Poland
In 2009, the European Carbon Association (ECA) has created a new award to recognise a significant contribution to the European carbon science community carried-out by a scientist from anywhere in the world, or a remarkable service to the worldwide carbon community carried-out by a scientist from Europe. The ECA Award will be presented at each World Conference on Carbon organized by one of the national carbon groups of the ECA, that is to say, every three years.
The award will be made on the recommendation of the ECA Award Committee and seeks to honour “Remarkable service to carbon science community” with the recipient holding the respect of their colleagues and “having been influential and supportive contribution in providing a strong foundation to the community of carbon scientists and technologists in order to promote a flourishing and healthy environment for scientific achievement”.
This Award was created in 2009 and is given every 3 years at the occasion of the European edition of the World Conference on Carbon. The laureate is selected by votes from the ECA members' representatives among nominations made by individuals. In 2012 Professor Yury Gogotsi (Drexel University, USA) will receive this award.
By giving this Award to Professor Yury Gogotsi (Drexel university, USA), the ECA has wished to acknowledge his involvement in the education and training of young carbon-scientist-to-be students, as well as his contribution and beneficial input to the research activity of several European laboratories and/or Groups in france, Germany, and Ukraine.
Source: http://www.carbon2012.pl/
MX-MAP project participants from MRC Dr. Oleksiy Gogotsi and Veronika Zahorodna performed split secondment visit to project partner organization University of Padova (Italy). MX-MAP project works on development of the key strategies for MXene medical applications. 
CanbioSe Project Meeting and Project Workshop was held at European Institute of Membranes (IEM), University of Montpellier, France on September 26-27, 2023. The workshop was focused on the theme of "Commercializing Biosensors, Intellectual Property, and Knowledge Transfer from Academia to Industry.
Dr. Oleksiy Gogotsi and Veronika Zahorodna visited IEEE NAP 2023 conference held in Bratislava on September 10-15, 2023. The prime focus of the IEEE NAP-2023 was on nanoscale materials with emphasis on interdisciplinary research exploring and exploiting their unique physical and chemical proprieties for practical applications.
Director of MRC and Carbon-Ukraine Dr. Oleksiy Gogotsi visited CEST labs in Wiener Neustadt (Low Energy Ion Scattering, Batteries development) and TU Vienna (ELSA, SFA). He meet with Dr. Pierluigi Bilotto, Dr. Chriatian Pichler and their colleagues, discussing novel materials and r&d activities for new technologies.
MX-MAP Session was held during the YUCOMAT Conference 2023 titled: "Towards MXenes’ biomedical applications by high-dimensional immune MAPping", HORIZON-MSCA-2021-SE-01 project MX-MAP.
CANBIOSE project participants from MRC Dr. Oleksiy Gogotsi and Veronika Zahorodna performed secondment visit to project partner organization European Institute of Membranes in Montpellier (France) on August -September 2023.
MRC researchers Dr. Oleksiy Gogotsi and Veronika Zahorodna were visiting Nanobiomedical Centre, Adam Mickewicz University in Poznan, Poland due to close collaboration with AMU team led by Dr. Igor Iatsunskiy. 
Meeting during the MXene international conference held in Drexel University on Aug. 3, 2022, and discussing the roadmap for launching MX-MAP research project on MXenes for medical applications.
Presenting our recent collaborative research paper on MXene use for PPT anticancer therapy, the biocompatibility of MXenes in vitro and in vivo studies: